DrugPatentWatch Database Preview
Osmotica Pharm Us Company Profile
What is the competitive landscape for OSMOTICA PHARM US, and what generic and branded alternatives to OSMOTICA PHARM US drugs are available?
OSMOTICA PHARM US has three approved drugs.
Summary for Osmotica Pharm Us
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Osmotica Pharm Us
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Osmotica Pharm Us | OXYBUTYNIN CHLORIDE | oxybutynin chloride | TABLET, EXTENDED RELEASE;ORAL | 078503-002 | Feb 4, 2009 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Osmotica Pharm Us | NIFEDIPINE | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 077127-003 | Oct 3, 2007 | AB2 | RX | No | No | Start Trial | Start Trial | ||||
| Osmotica Pharm Us | OXYBUTYNIN CHLORIDE | oxybutynin chloride | TABLET, EXTENDED RELEASE;ORAL | 078503-003 | Feb 4, 2009 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Osmotica Pharm Us | NIFEDIPINE | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 077127-002 | Nov 21, 2005 | AB2 | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
